Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 281 to 290 of 341

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancerTA310
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Cancer services for children and young peopleQS55
Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatmentESUOM21
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancerHTG316
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancerHTG315
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancerTA284
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancerTA285
Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumabESNM13
Irreversible electroporation for treating primary lung cancer and metastases in the lungHTG302

Results per page

  1. 10
  2. 25
  3. 50
  4. All